Frequency and Impact of Adverse Events in Patients Undergoing Surgery for End-stage Ankle Arthritis

Category: Ankle Arthritis Introduction/Purpose: Patients seeking surgical treatment for ESAA have two primary treatment options: arthrodesis and arthroplasty. While there are comparative trials that address treatment options, neither the complication risk or the relative effectiveness is clearly est...

Full description

Bibliographic Details
Main Authors: Bruce Sangeorzan MD, J. Chris Coetzee MD, Donald Bohay MD, FACS, John Anderson MD, James Davitt MD, Michael Houghton MD, John Maskill MD, Michael Brage MD, Daniel Norvell PhD, Jane Shofer MS, William Ledoux PhD
Format: Article
Language:English
Published: SAGE Publishing 2018-09-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/2473011418S00417
id doaj-51d5642a385a41e1bd18cfa36d536e9d
record_format Article
spelling doaj-51d5642a385a41e1bd18cfa36d536e9d2020-11-25T03:39:18ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142018-09-01310.1177/2473011418S00417Frequency and Impact of Adverse Events in Patients Undergoing Surgery for End-stage Ankle ArthritisBruce Sangeorzan MDJ. Chris Coetzee MDDonald Bohay MD, FACSJohn Anderson MDJames Davitt MDMichael Houghton MDJohn Maskill MDMichael Brage MDDaniel Norvell PhDJane Shofer MSWilliam Ledoux PhDCategory: Ankle Arthritis Introduction/Purpose: Patients seeking surgical treatment for ESAA have two primary treatment options: arthrodesis and arthroplasty. While there are comparative trials that address treatment options, neither the complication risk or the relative effectiveness is clearly established. The focus of this study was to report the magnitude of all AEs (as defined by DSMB) in the peri operative and early healing period after ankle surgery and evaluate the impact of these AEs on patient functional outcomes Methods: We report data from a multi-site prospective cohort study performed to compare ankle arthroplasty to ankle arthrodesis in the treatment of ESAA among six participating sites that required AE reporting under FDA required defintions. We compared the risk and impact of non-ankle AEs and ankle-specific AEs versus no AEs controlling for potential confounding factors including surgical procedure using multinomial logistic regression. We estimated differences in post-op functional outcomes by AE occurrence using linear mixed effects regression. Results: Among 517 patients who had surgery from 2012 to 2015 and completed the full baseline assessment, follow up was available in 494 (95%) patients. There were 628 reported AEs (477 in the arthroplasty group and 151 in the arthrodesis group), occurring in 261 (63%) arthroplasty patients and 67 (65%) arthrodesis patients. There were 50 (8%) ankle specific AEs. The odds ratio for the risk of an ankle specific AE and non-ankle specific AE versus no AE was 1.84, 95% CI (.85, 3.98) and .96, 95% CI (.57, 1.61), respectively, for those receiving arthrodesis compared to arthroplasty. Patients experiencing ankle-specific AEs had significantly less improvement in FAAM Sports and ADL subscores and worst pain outcomes; however, both groups improved significantly in all measures except mental health. Conclusion: Ankle specific AEs were infrequent and only weakly associated with surgical procedure (slightly more in arthrodesis). While patients improved in all functional outcomes except mental health, regardless of AE occurrence, ankle-specific AEs negatively impacted patient improvement compared to those with no AEs or a non-ankle AE.https://doi.org/10.1177/2473011418S00417
collection DOAJ
language English
format Article
sources DOAJ
author Bruce Sangeorzan MD
J. Chris Coetzee MD
Donald Bohay MD, FACS
John Anderson MD
James Davitt MD
Michael Houghton MD
John Maskill MD
Michael Brage MD
Daniel Norvell PhD
Jane Shofer MS
William Ledoux PhD
spellingShingle Bruce Sangeorzan MD
J. Chris Coetzee MD
Donald Bohay MD, FACS
John Anderson MD
James Davitt MD
Michael Houghton MD
John Maskill MD
Michael Brage MD
Daniel Norvell PhD
Jane Shofer MS
William Ledoux PhD
Frequency and Impact of Adverse Events in Patients Undergoing Surgery for End-stage Ankle Arthritis
Foot & Ankle Orthopaedics
author_facet Bruce Sangeorzan MD
J. Chris Coetzee MD
Donald Bohay MD, FACS
John Anderson MD
James Davitt MD
Michael Houghton MD
John Maskill MD
Michael Brage MD
Daniel Norvell PhD
Jane Shofer MS
William Ledoux PhD
author_sort Bruce Sangeorzan MD
title Frequency and Impact of Adverse Events in Patients Undergoing Surgery for End-stage Ankle Arthritis
title_short Frequency and Impact of Adverse Events in Patients Undergoing Surgery for End-stage Ankle Arthritis
title_full Frequency and Impact of Adverse Events in Patients Undergoing Surgery for End-stage Ankle Arthritis
title_fullStr Frequency and Impact of Adverse Events in Patients Undergoing Surgery for End-stage Ankle Arthritis
title_full_unstemmed Frequency and Impact of Adverse Events in Patients Undergoing Surgery for End-stage Ankle Arthritis
title_sort frequency and impact of adverse events in patients undergoing surgery for end-stage ankle arthritis
publisher SAGE Publishing
series Foot & Ankle Orthopaedics
issn 2473-0114
publishDate 2018-09-01
description Category: Ankle Arthritis Introduction/Purpose: Patients seeking surgical treatment for ESAA have two primary treatment options: arthrodesis and arthroplasty. While there are comparative trials that address treatment options, neither the complication risk or the relative effectiveness is clearly established. The focus of this study was to report the magnitude of all AEs (as defined by DSMB) in the peri operative and early healing period after ankle surgery and evaluate the impact of these AEs on patient functional outcomes Methods: We report data from a multi-site prospective cohort study performed to compare ankle arthroplasty to ankle arthrodesis in the treatment of ESAA among six participating sites that required AE reporting under FDA required defintions. We compared the risk and impact of non-ankle AEs and ankle-specific AEs versus no AEs controlling for potential confounding factors including surgical procedure using multinomial logistic regression. We estimated differences in post-op functional outcomes by AE occurrence using linear mixed effects regression. Results: Among 517 patients who had surgery from 2012 to 2015 and completed the full baseline assessment, follow up was available in 494 (95%) patients. There were 628 reported AEs (477 in the arthroplasty group and 151 in the arthrodesis group), occurring in 261 (63%) arthroplasty patients and 67 (65%) arthrodesis patients. There were 50 (8%) ankle specific AEs. The odds ratio for the risk of an ankle specific AE and non-ankle specific AE versus no AE was 1.84, 95% CI (.85, 3.98) and .96, 95% CI (.57, 1.61), respectively, for those receiving arthrodesis compared to arthroplasty. Patients experiencing ankle-specific AEs had significantly less improvement in FAAM Sports and ADL subscores and worst pain outcomes; however, both groups improved significantly in all measures except mental health. Conclusion: Ankle specific AEs were infrequent and only weakly associated with surgical procedure (slightly more in arthrodesis). While patients improved in all functional outcomes except mental health, regardless of AE occurrence, ankle-specific AEs negatively impacted patient improvement compared to those with no AEs or a non-ankle AE.
url https://doi.org/10.1177/2473011418S00417
work_keys_str_mv AT brucesangeorzanmd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT jchriscoetzeemd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT donaldbohaymdfacs frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT johnandersonmd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT jamesdavittmd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT michaelhoughtonmd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT johnmaskillmd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT michaelbragemd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT danielnorvellphd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT janeshoferms frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
AT williamledouxphd frequencyandimpactofadverseeventsinpatientsundergoingsurgeryforendstageanklearthritis
_version_ 1724539726243823616